Data · Medical · India

SS Innovations installs 30 SSi Mantra surgical robots in Q2 as revenue rises 39%

The Indian surgical robot maker has 224 systems in 12 countries, but margins fell and it is losing money again.

A surgeon positions a draped SSi Mantra robotic arm during a gallbladder removal at Medanta hospital in Gurugram.SS Innovations press image
A surgeon positions a draped SSi Mantra robotic arm during a gallbladder removal at Medanta hospital in Gurugram. SS Innovations press image · source

SS Innovations, the Nasdaq-listed maker of the SSi Mantra surgical robot, which is developed and built in India, reported revenue of US$13.9 million for the quarter to June, up 39.4% on the year. It installed 30 SSi Mantra systems, up from 23 a year earlier. First-half revenue rose 65.6% to US$25.0 million.

The installed base reached 224 systems across 12 countries, and 12,272 surgeries have been done on them. Gross margin fell to 50.9% from 59.1%, and the net loss widened to US$2.7 million from US$0.3 million. Cash and equivalents, excluding restricted cash, were US$13.6 million at the end of June.

SSi Mantra competes on price with Intuitive's da Vinci in Indian hospitals. The company expects the US FDA to finish reviewing its 510(k) application by the end of the first quarter of 2027. US clearance is the main test of whether an Indian-built surgical robot can sell in the biggest market.

This story was drafted with AI from the sources above and checked by a 9DOF editor before publishing. Figures are as reported by the sources. Spot an error? Tell us and we'll correct it on this page.

The weekly

Robotics and drones, every Monday.

NEWS · DEALS · EVENTS · ALSO ON TELEGRAM

One email a week. We'll ask you to confirm before the first issue. Unsubscribe any time.

Cookie settings

EssentialSign-in, security, language, theme and this choice.
Always on
Privacy policy

Sign in

or with email